CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018. (31st December 2020)

• Record Type: Journal Article
• Authors: Lee, Jennifer S; Humes, Elizabeth A; Hogan, Brenna C; Buchacz, Kate; Eron, Joseph J; Gill, M John; Sterling, Timothy R; Rebeiro, Peter F; Lima, Viviane Dias; Mayor, Angel; Silverberg, Michael J; Horberg, Michael A; Moore, Richard D; Althoff, Keri N
• Is Part Of: Clinical infectious diseases. Volume 73:Number 7(2021)
• Page Start: e2334
• Page End: e2337
• Publication Date: 2020-12-31
• Subjects: HIV -- CD4 count -- antiretroviral therapy -- universal treatment -- treat all; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciaa1904
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/μL, and CD4 count at ART prescription increased from 160 to 364 cells/μL.